Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
380.20
0.00 (0.00%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $10.04 billion as of September 15, 2026. Its market cap has increased by 33.04% in one year.
Market Cap
10.04B
Enterprise Value
9.79B
1-Year Change
33.04%
Ranking
Category
Stock Price
$380.20
ChartMarket Cap Chart
Since September 16, 2021, Bio-Rad Laboratories's market cap has decreased from $23.41B to $10.04B, a decrease of -57.11%. That is a compound annual growth rate of -15.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 10.04B | 22.94% |
| Dec 31, 2025 | 8.17B | -11.01% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | -3.40% |
| Sep 16, 2021 | 23.41B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STERIS | 20.83B |
| Zimmer Biomet Holdings | 18.41B |
| Penumbra | 12.60B |
| Smith & Nephew | 11.89B |
| Globus Medical | 10.17B |
| Glaukos | 10.09B |
| Bio-Rad Laboratories | 9.85B |
| Insulet | 9.56B |